Prevention of second primary cancers in head and neck cancer patients: new perspectives.
Not all head and neck cancer patients have the same chance to develop second primary cancers. New evidence suggests that it is possible to select high-risk patients. Other new developments in Europe are intensive screening, not only during initial work-up but also during follow-up, and chemoprevention of second primaries by retinol and n-acetyl-cystein.